We present a single-field string inflationary model which allows for the generation of primordial black holes in the low mass region where they can account for a significant fraction of the dark matter abundance. The potential is typical of type IIB fibre inflation models and features a plateau at CMB scales and a near inflection point at large distance scales where the power spectrum is enhanced due to a period of ultra slow-roll. The tunability of the underlying parameters is guaranteed by scanning through the string landscape and their stability against quantum corrections is ensured by an effective shift symmetry.
Abstract:We construct explicit examples of fibre inflation models which are globally embedded in type IIB orientifolds with chiral matter on D7-branes and full closed string moduli stabilisation. The minimal setup involves a Calabi-Yau threefold with h 1,1 = 4 Kähler moduli which features multiple K3 fibrations and a del Pezzo divisor supporting nonperturbative effects. We perform a consistent choice of orientifold involution, brane setup and gauge fluxes which leads to chiral matter and a moduli-dependent Fayet-Iliopoulos term. After D-term stabilisation, the number of Kähler moduli is effectively reduced to 3 and the internal volume reduces to the one of fibre inflation models. The inflationary potential is generated by suitable string loop corrections in combination with higher derivative effects. We analyse the inflationary dynamics both in the single-field approximation and by numerically deriving the full multi-field evolution in detail. Interestingly, we find that the Kähler cone conditions set strong constraints on the allowed inflaton field range.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.